Prescient Therapeutics Limited
PSTTF
Price:
$0.145
Market Cap:
$73.61M
Operating from Melbourne, Australia, Prescient Therapeutics Limited is a clinical-stage oncology company dedicated to pioneering novel pharmaceutical treatments for a variety of cancers. The company's primary investigational therapy, PTX-200, is currently undergoing several advanced clinical trials: a Phase 2a study for HER2-negative breast cancer, a Phase 1B/2 trial addressing relapsed and refractory acute myeloid leukemia (AML), and a Phase 1b trial for platinum-resistant ovarian cancer that has recurred or persisted. Another key pipeline asset is PTX-100, a RhoA inhibitor, engineered to combat both blood and solid tumors, particularly those characterized by specific Ras and RhoA genetic m...[Read more]
Industry
Biotechnology
IPO Date
2017-09-13
Stock Exchange
OTC
Ticker
PSTTF
PE Ratio
[-29.00]
ROE
[-62.49%]
Current Ratio
[12.95]
Dividend Yield
[0%]
Enterprise Value
[64.33M]
Dividend History
The ROE as of June 2026 (TTM) for Prescient Therapeutics Limited (PSTTF) is -62.49%
According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is -62.49%. This represents a change of 132.49% compared to the average of -26.88% of the last 4 quarters.
Prescient Therapeutics Limited (PSTTF) Historical ROE (quarterly & annually)
How has PSTTF ROE performed in the past?
The mean historical ROE of Prescient Therapeutics Limited over the last ten years is -30.63%. The current -62.49% ROE has changed 103.98% with respect to the historical average. Over the past ten years (40 quarters), PSTTF's ROE was at its highest in in the June 2009 quarter at 111.34%. The ROE was at its lowest in in the June 2008 quarter at -1214.20%.
Average
-30.63%
Median
-27.07%
Minimum
-64.31%
Maximum
-13.48%
Prescient Therapeutics Limited (PSTTF) ROE by Quarter and Year
Discovering the peaks and valleys of Prescient Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.73%
Maximum Annual ROE = -13.48%
Minimum Annual Increase = -71.88%
Minimum Annual ROE = -64.31%
| Year | ROE | Change |
|---|---|---|
| 2025 | -64.31% | 41.03% |
| 2024 | -45.60% | 69.73% |
| 2023 | -26.86% | -12.00% |
| 2022 | -30.53% | 50.30% |
| 2021 | -20.31% | -31.57% |
| 2020 | -29.68% | 11.95% |
| 2019 | -26.51% | -2.77% |
| 2018 | -27.27% | 25.14% |
| 2017 | -21.79% | 61.66% |
| 2016 | -13.48% | -71.88% |
Prescient Therapeutics Limited (PSTTF) Average ROE
How has PSTTF ROE performed in the past?
The current ROE of Prescient Therapeutics Limited (PSTTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-45.59%
5-year avg
-37.52%
10-year avg
-30.63%
Prescient Therapeutics Limited (PSTTF) ROE vs. Peers
How is PSTTF’s ROE compared to its peers?
Prescient Therapeutics Limited’s ROE is greater than Eupraxia Pharmaceuticals Inc. (-50.81%), greater than AnGes, Inc. (-156.47%), greater than Adocia S.A. (-3796.57%), greater than Ascentage Pharma Group International (-123.61%), greater than Mind Cure Health Inc. (-102.08%), greater than Anteris Technologies Ltd (-715.34%), greater than China Medical & HealthCare Group Limited (-1.49%), less than Leafly Holdings, Inc. (17.16%), less than Japan Medical Dynamic Marketing, Inc. (1.07%), less than Cell MedX Corp. (60.42%),
| Company | ROE | Market cap |
|---|---|---|
| -50.81% | $108.29M | |
| -156.47% | $142.50M | |
| -3796.57% | $103.66M | |
| -123.61% | $127.31M | |
| -102.08% | $86.53M | |
| -715.34% | $120.50M | |
| -1.49% | $123.01M | |
| 17.16% | $114.90M | |
| 1.07% | $156.35M | |
| 60.42% | $126.33M |
Build a custom stock screener for Prescient Therapeutics Limited (PSTTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Prescient Therapeutics Limited (PSTTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Prescient Therapeutics Limited's ROE?
How is the ROE calculated for Prescient Therapeutics Limited (PSTTF)?
What is the highest ROE for Prescient Therapeutics Limited (PSTTF)?
What is the 3-year average ROE for Prescient Therapeutics Limited (PSTTF)?
What is the 5-year average ROE for Prescient Therapeutics Limited (PSTTF)?
How does the current ROE for Prescient Therapeutics Limited (PSTTF) compare to its historical average?